QRX 0.00% 2.8¢ qrxpharma ltd

Ann: Interim Analysis of Final Pivotal Phase 3 St, page-3

  1. 792 Posts.
    lightbulb Created with Sketch. 17
    re: Ann: Interim Analysis of Final Pivotal Ph... i agree this must be the lowest risk bio on market so close to fda approval and $20 m in the bank. buying anything below 90c
 
watchlist Created with Sketch. Add QRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.